WallStreetZenWallStreetZen

NASDAQ: SABS
Sab Biotherapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Sab Biotherapeutics revenue was $1.32M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $114.7k, up Infinity% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SABS annual revenue was $1.3M, with -40.9% growth year-over-year.

SABS past revenue growth

How has SABS's revenue growth performed historically?

Company
-40.94%
Industry
497.69%
Market
20.68%
SABS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SABS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SABS's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SABS revenue history

Current Revenue
$1.3M
Current Earnings
-$34.1M
Current Profit Margin
-2,579%

Be the first to know when SABS announces revenue.

SABS Revenue History By Year

SABS Yearly RevenueSABS RevenueSABS ChangeSABS Revenue Growth
2024-12-31$1.32M-$916.58k-40.94%
2023-12-31$2.24M-$21.67M-90.63%
2022-12-31$23.90M-$36.97M-60.73%
2021-12-31$60.88M$5.64M+10.21%
2020-12-31$55.24M$51.80M+1,504.91%
2019-12-31$3.44MN/AN/A

1 of 1

Sab Biotherapeutics Revenue FAQ

What was SABS's revenue last quarter?

On Invalid Date, Sab Biotherapeutics (NASDAQ: SABS) reported Q4 2024 revenue of $114.70 thousand up 62.4% year over year. In the same quarter last year, Sab Biotherapeutics's revenue was $305.01 thousand.

What was Sab Biotherapeutics's revenue in 2024?

Sab Biotherapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $1.32 million, a 40.94% decrease year over year.

How much does Sab Biotherapeutics make in a day?

Based on Sab Biotherapeutics annual revenue for the past five years, SABS makes an average of $78,673.65 per day.

What was Sab Biotherapeutics's annual revenue growth in the past year?

As of Q2 2025, Sab Biotherapeutics's revenue has grown -40.94% year over year. This is 538.63 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Sab Biotherapeutics's revenue in the past year totaled $1.32 million.

How much does Sab Biotherapeutics make in a year?

Sab Biotherapeutics's revenue by year for the past five years is:
  • Sab Biotherapeutics's revenue for the twelve months ending Dec 31, 2024 was $1.32 million, a 40.94% decrease year over year.
  • Sab Biotherapeutics's annual revenue for Dec 31, 2023 was $2.24 million, a 90.63% decrease from 2022.
  • Sab Biotherapeutics's annual revenue for 2022 was $23.90 million, a 60.73% decrease from 2021.
  • Sab Biotherapeutics's annual revenue for 2021 was $60.88 million, a 10.21% increase from 2020.
  • Sab Biotherapeutics's annual revenue for 2020 was $55.24 million, a 1,504.91% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.